Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study.

Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study.
复制标题

吡仑帕奈辅助治疗中国局灶性癫痫发作患者的疗效和耐受性:一项观察性、前瞻性研究

DOI:
10.3389/fneur.2021.731566
复制
发表时间:
2021
影响因子:
3.4
通讯作者:
Liu X
Liu X
中科院分区:
医学3区
文献类型:
--
作者:
Zhang R;Qiao S;Fang X;Wang K;Shi Y;Du Q;Yang T;Liu X

文献摘要

参考文献

相似文献

目的:评估吡仑帕奈(PER)辅助治疗中国局灶性癫痫发作(伴或不伴继发性全身强直阵挛性癫痫发作)患者的疗效和耐受性。方法:这项单中心前瞻性观察研究连续招募了 56 名年龄在 14-72 岁的患者。所有患者根据临床判断接受 PER 作为附加治疗。引入 PER 后 3 个月和 6 个月获得癫痫发作频率、不良事件 (AE) 和保留率。结果:3个月和6个月后的总体有效率分别为60%和71.1%,同一时间点的癫痫发作自由度分别为8%和15.8%。 3 个月随访时的保留率为 89.3%,6 个月随访时的保留率为 67.9%。不良事件的总体发生率为55.4%。报告的主要 AE 是头晕(39.3%)和嗜睡(25%)。结论:我们的研究证实了辅助 PER 在现实生活中对中国患者的疗效和耐受性。根据我们的治疗经验,中国患者需要较低的 PER 维持剂量。
Purpose: To evaluate the efficacy and tolerability of adjunctive perampanel (PER) in Chinese patients with focal-onset seizures, with or without secondarily generalized tonic-clonic seizures. Methods: Fifty-six patients aged 14–72 years were recruited consecutively in this single-center prospective observational study. All patients received PER as add-on treatment on the basis of clinical judgment. Seizure frequency, adverse events (AEs), and retention rates were obtained at 3 and 6 months after PER introduction. Results: The overall response rates were 60 and 71.1% after 3 and 6 months, respectively, and the freedom of seizures at the same points were reached in 8 and 15.8%. The retention rates were 89.3% at the 3-month follow-up and 67.9% at the 6-month follow-up. The overall incidence of adverse events was 55.4%. The leading reported AEs were dizziness (39.3%) and somnolence (25%). Conclusions: Our study confirmed the efficacy and tolerability of adjunctive PER in Chinese patients in real-life conditions. Based on our treatment experience, a lower maintenance dose of PER would be needed in Chinese patients.
DOI: 10.1016/j.yebeh.2021.108069
发表时间: 2021-05-30
影响因子: 2.6
作者:
Fernandes, Mariana;Dainese, Filippo;Liguori, Claudio
通讯作者: Liguori, Claudio
DOI: 10.1016/j.seizure.2020.09.026
发表时间: 2020-12-01
影响因子: 3
作者:
Santamarina, Estevo;Bertol, Vicente;Casadevall, Teresa
通讯作者: Casadevall, Teresa
DOI: 10.1111/epi.13709
发表时间: 2017-04
期刊: Epilepsia
影响因子: 5.6
作者:
Scheffer IE;Berkovic S;Capovilla G;Connolly MB;French J;Guilhoto L;Hirsch E;Jain S;Mathern GW;Moshé SL;Nordli DR;Perucca E;Tomson T;Wiebe S;Zhang YH;Zuberi SM
通讯作者: Zuberi SM
DOI: 10.1016/j.jns.2018.04.017
发表时间: 2018-07-15
影响因子: 4.4
作者:
Morano, Alessandra;Fattouch, Jinane;Di Bonaventura, Carlo
通讯作者: Di Bonaventura, Carlo
DOI: 10.1016/j.yebeh.2019.106876
发表时间: 2020-03-01
影响因子: 2.6
作者:
Pina-Garza, J. Eric;Rosenfeld, William;Malhotra, Manoj
通讯作者: Malhotra, Manoj